-
-
-
-
-
-
-
bioAffinity Technologies Announces Record 2025 Revenue and Unit Sales for Flagship Lung Cancer Diagnostic CyPath® Lung
-
-
-
-
-
-
-
bioAffinity Technologies Reports $2.4 Million Revenue for Q2 Driven by Growing CyPath® Lung Sales
-
-
-
-
-
-
-
bioAffinity Technologies Reports First Quarter 2023 Financial Results
-
-
-
-
1,206,259 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

